<DOC>
	<DOC>NCT01178632</DOC>
	<brief_summary>Phase III, double blind, randomized study, controlled by Valeriana officinalis L for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L. in generalized anxiety disorder. The treatment period will last four weeks and be followed by a post treatment visit.</brief_summary>
	<brief_title>Therapeutic Effect of an Herbal Medicine on Anxiety</brief_title>
	<detailed_description>The main objective of this study is to evaluate the clinical efficacy of the drug PassiflorineÂ® (Passiflora incarnata L; Crataegus Oxyacantha L and Salix alba L) compared to Valeriana officinalis over a period of four weeks. The improvement of anxiety disorders parameters (primary outcome) will be measured by the score of the Hamilton Anxiety Scale (HAM-A). Does the administration of 2 tablets a day over a period of four weeks vs. Valeriana officinalis lead to an improvement in anxiety disorders?</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Clinical diagnosis of generalized anxiety disorder HAMA scale &gt; 17 and &lt;30 HAMA scale &gt; 30 Psychotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Herbal</keyword>
	<keyword>Phytotherapy</keyword>
	<keyword>Passiflora</keyword>
	<keyword>Valeriana</keyword>
	<keyword>Anxiety</keyword>
</DOC>